Full Text
POSB99 The Cost-Effectiveness of Biologic/Targeted Synthetic/Biosimilar Disease Modifying Antirheumatic Drugs: A Systematic Review

Abstract

Authors

K Peng X Li X Tong F Cheng

Back to ISPOR Europe 2021 Abstracts: Emerging Frontiers and Opportunities
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×